American Century Companies Inc. Increases Holdings in Doximity, Inc. (NASDAQ:DOCS)

American Century Companies Inc. lifted its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 0.9% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 209,772 shares of the company’s stock after purchasing an additional 1,786 shares during the quarter. American Century Companies Inc.’s holdings in Doximity were worth $5,867,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Norges Bank purchased a new position in shares of Doximity during the 4th quarter valued at about $35,995,000. Blair William & Co. IL increased its stake in Doximity by 31.7% in the 1st quarter. Blair William & Co. IL now owns 90,600 shares of the company’s stock worth $2,438,000 after purchasing an additional 21,787 shares during the period. Pinebridge Investments L.P. purchased a new position in Doximity in the 4th quarter worth approximately $2,845,000. Acadian Asset Management LLC increased its stake in Doximity by 128.7% in the 1st quarter. Acadian Asset Management LLC now owns 96,442 shares of the company’s stock worth $2,590,000 after purchasing an additional 54,281 shares during the period. Finally, Nisa Investment Advisors LLC increased its stake in Doximity by 15,714.3% in the 2nd quarter. Nisa Investment Advisors LLC now owns 11,070 shares of the company’s stock worth $310,000 after purchasing an additional 11,000 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Stock Down 0.3 %

NASDAQ DOCS opened at $41.37 on Wednesday. Doximity, Inc. has a twelve month low of $19.71 and a twelve month high of $41.87. The firm has a market capitalization of $7.67 billion, a PE ratio of 57.46, a P/E/G ratio of 5.15 and a beta of 1.27. The stock’s 50 day moving average is $33.73 and its 200 day moving average is $29.19.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, August 8th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.16 by $0.06. Doximity had a return on equity of 19.26% and a net margin of 32.53%. The business had revenue of $126.68 million for the quarter, compared to the consensus estimate of $119.88 million. On average, research analysts anticipate that Doximity, Inc. will post 0.8 earnings per share for the current year.

Insiders Place Their Bets

In other Doximity news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $35.00, for a total value of $1,050,000.00. Following the sale, the chief financial officer now directly owns 309,627 shares of the company’s stock, valued at $10,836,945. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Watkin Phoebe L. Yang sold 1,011 shares of the stock in a transaction on Monday, August 5th. The stock was sold at an average price of $25.54, for a total transaction of $25,820.94. Following the sale, the director now directly owns 11,258 shares of the company’s stock, valued at $287,529.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Anna Bryson sold 30,000 shares of the stock in a transaction on Friday, August 9th. The shares were sold at an average price of $35.00, for a total value of $1,050,000.00. Following the sale, the chief financial officer now directly owns 309,627 shares in the company, valued at $10,836,945. The disclosure for this sale can be found here. Over the last three months, insiders have sold 37,951 shares of company stock valued at $1,271,018. 39.40% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

DOCS has been the topic of a number of analyst reports. Morgan Stanley lifted their price target on Doximity from $25.00 to $26.00 and gave the stock an “underweight” rating in a research note on Friday, August 9th. JPMorgan Chase & Co. lifted their price target on Doximity from $27.00 to $30.00 and gave the stock a “neutral” rating in a research note on Monday, August 19th. Barclays lifted their price objective on Doximity from $31.00 to $35.00 and gave the stock an “equal weight” rating in a research report on Friday, August 9th. Evercore ISI lifted their price objective on Doximity from $29.00 to $34.00 and gave the stock an “in-line” rating in a research report on Friday, August 9th. Finally, Truist Financial reiterated a “hold” rating and issued a $35.00 price objective (up from $31.00) on shares of Doximity in a research report on Wednesday, August 14th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Doximity has a consensus rating of “Hold” and an average price target of $32.42.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.